Pharvaris N.V. (FWB:9EN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Meeker Other companies: Kardigan, Inc. (Board of Directors · Since at least Jun 17, 2026); Trevi Therapeutics, Inc. (Chairman · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Chairman, President, and Chief Executive Officer · Since at least Oct 4, 2017); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); MyoKardia Inc (Director · Apr 17, 2017 – Nov 17, 2020 · Past); Savient Pharmaceuticals Inc (Director · Jan 7, 2013 – Jan 7, 2013 · Past) | Chair of the Board · Since at least Mar 18, 2026 |
| Berndt Modig Other companies: Sio Gene Therapies Inc (Director · Apr 29, 2016 – Apr 15, 2021 · Past) | Chief Executive Officer, Director · Since at least Mar 17, 2026 |
| Elisabeth Björk Other companies: Rocket Pharmaceuticals, Inc. (Director · Since at least Apr 20, 2020) | Director · Since at least Mar 18, 2026 |
| Viviane Monges Other companies: ADC Therapeutics SA (Non-Executive Director · Since at least Jun 1, 2026) | Director · Since at least May 21, 2026 |
| Anna Nijdam | Head, Strategic Finance and Principal Accounting Officer · Since at least Apr 1, 2026 |
| Anne Lesage | Chief Early Development Officer · Since at least Mar 18, 2026 |
| Annick Deschoolmeester | Chief Human Resources Officer · Since at least Mar 18, 2026 |
| David Nassif | Chief Financial Officer & Chief Legal Officer · Since at least May 21, 2026 |
| Hans Schikan | Vice Chair of the Board · Since at least Nov 5, 2026 |
| Johannes Gerardus Christiaan Petrus Schikan | Director · Since at least Mar 17, 2026 |
| Maggie Beller | Vice President, Head of Corporate and Investor Communications · Since at least Sep 8, 2026 |
| Peng Lu | President · Since at least Mar 18, 2026 |
| Peng Lu | President · Since at least Oct 5, 2026 |
| Robert Glassman | Director · Since at least Mar 17, 2026 |
| Stefan Abele | Chief Technical Operations Officer · Since at least Mar 18, 2026 |
| Wim Souverijns | Chief Commercial Officer · Since at least Jan 13, 2025 |